Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACE2,Angiotensin-converting enzyme 2,48693,163,1.46 [1.17-1.83],0.000747350050109
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACVRL1,Serine/threonine-protein kinase receptor R3,49142,166,2.19 [1.34-3.57],0.0016716764691252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADA2,Adenosine deaminase 2,49318,166,1.56 [1.16-2.11],0.0031694025616301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,41967,124,1.97 [1.37-2.84],0.0002549082655781
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL2,ADAMTS-like protein 2,43224,130,2.11 [1.38-3.22],0.0005632184044269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADIPOQ,Adiponectin,43287,129,1.48 [1.16-1.89],0.001407312628577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADM,Pro-adrenomedullin,50024,168,2.35 [1.39-3.98],0.0014379560425086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGRN,Agrin,49821,165,1.83 [1.31-2.54],0.0003657109815856
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMBP,Protein AMBP,49953,168,2.75 [1.44-5.25],0.0021254765524624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPT2,Angiopoietin-2,50024,168,2.26 [1.64-3.12],6.431951268557611e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL1,Angiopoietin-related protein 1,48888,162,2.26 [1.41-3.62],0.0007231885917464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL4,Angiopoietin-related protein 4,49744,165,1.77 [1.31-2.39],0.0002299237718556
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA2,Annexin A2,41458,123,1.38 [1.14-1.68],0.0012162787249562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AREG,Amphiregulin,49371,166,1.87 [1.44-2.44],3.544623822731373e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASGR1,Asialoglycoprotein receptor 1,49224,166,1.76 [1.15-2.71],0.0097279209485127
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B2M,Beta-2-microglobulin,43287,129,1.51 [1.15-1.98],0.0028771557370637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B4GALT1,"Beta-1,4-galactosyltransferase 1",49821,165,2.27 [1.43-3.61],0.0005326756483951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,48422,162,1.34 [1.10-1.62],0.0037077982589924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAN,Brevican core protein,49224,166,0.55 [0.37-0.81],0.0023849133211702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QA,Complement C1q subcomponent subunit A,49911,166,2.91 [1.66-5.11],0.0001976490506861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1R,Complement C1r subcomponent,43287,129,2.23 [1.28-3.89],0.0047463785725501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C7,Complement component C7,42241,127,3.55 [2.18-5.77],3.22577567220592e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA12,Carbonic anhydrase 12,49371,166,1.71 [1.16-2.51],0.0065615347460498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPG,Macrophage-capping protein,49235,166,1.41 [1.14-1.75],0.0016770436613578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC80,Coiled-coil domain-containing protein 80,49610,166,2.18 [1.57-3.01],2.677376029670745e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL11,Eotaxin,50157,167,1.64 [1.14-2.36],0.0081875274135562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL21,C-C motif chemokine 21,49821,165,1.52 [1.21-1.93],0.000431583486675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL22,C-C motif chemokine 22,49100,165,1.38 [1.08-1.76],0.0094814374104948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL23,C-C motif chemokine 23,49821,165,1.71 [1.25-2.34],0.0008121879670209
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL25,C-C motif chemokine 25,50157,167,1.69 [1.28-2.23],0.0001937920751468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL4,C-C motif chemokine 4,49660,165,1.24 [1.06-1.45],0.0077466309390691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN3,CCN family member 3,50140,168,1.65 [1.15-2.39],0.0071951002201251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN5,CCN family member 5,49619,166,1.73 [1.23-2.45],0.0016667595151385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD14,Monocyte differentiation antigen CD14,48607,165,1.73 [1.28-2.33],0.0003307662438702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD27,CD27 antigen,49753,165,1.55 [1.15-2.09],0.004395701382013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD274,Programmed cell death 1 ligand 1,49224,166,1.73 [1.22-2.46],0.0021392697071787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD276,CD276 antigen,49581,165,2.62 [1.78-3.85],9.00770073767278e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD302,CD302 antigen,49371,166,1.93 [1.30-2.86],0.0011021503816041
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD48,CD48 antigen,49744,165,1.79 [1.16-2.76],0.0090247140109699
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD59,CD59 glycoprotein,47829,159,2.02 [1.21-3.35],0.0069556020351263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD5L,CD5 antigen-like,43056,128,1.68 [1.19-2.37],0.0031647645683673
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD7,T-cell antigen CD7,41886,124,1.80 [1.30-2.48],0.0003415247356015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD74,HLA class II histocompatibility antigen gamma chain,50052,168,1.81 [1.25-2.61],0.001576606194761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD79B,B-cell antigen receptor complex-associated protein beta chain,50157,167,1.55 [1.19-2.03],0.0011951233396214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,49675,165,2.42 [1.32-4.46],0.0044320536136737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,49537,166,1.23 [1.06-1.43],0.00754603508196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,43224,130,1.51 [1.16-1.97],0.0024559437912194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,48693,163,1.66 [1.31-2.11],3.364000311244422e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFD,Complement factor D,43287,129,2.33 [1.32-4.14],0.0037640495496489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",43118,128,1.96 [1.40-2.73],7.437752739440814e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD6,MICOS complex subunit MIC25,43021,127,1.86 [1.22-2.83],0.0038525120420604
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHI3L1,Chitinase-3-like protein 1,48519,164,1.33 [1.14-1.54],0.000199564962348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRDL1,Chordin-like protein 1,49744,165,2.02 [1.34-3.06],0.0008713955098345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKAP4,Cytoskeleton-associated protein 4,49915,166,2.25 [1.56-3.26],1.5560000578147658e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKB,Creatine kinase B-type,43224,130,1.74 [1.32-2.28],8.31864820527501e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC11A,C-type lectin domain family 11 member A,49536,166,1.55 [1.16-2.06],0.0025884425060648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4D,C-type lectin domain family 4 member D,49537,166,1.46 [1.18-1.79],0.0003711033407835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC5A,C-type lectin domain family 5 member A,49448,166,2.04 [1.33-3.12],0.0010560822655655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC6A,C-type lectin domain family 6 member A,48422,162,1.51 [1.15-1.98],0.0027510043619775
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLMP,CXADR-like membrane protein,50024,168,2.73 [1.55-4.83],0.0005393182369352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN2,Calsyntenin-2,50157,167,1.88 [1.42-2.47],8.558636118693356e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL18A1,Collagen alpha-1(XVIII) chain,49816,167,3.75 [2.17-6.49],2.238715174130019e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL4A1,Collagen alpha-1(IV) chain,49610,166,2.04 [1.49-2.80],8.173604783828979e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL6A3,Collagen alpha-3(VI) chain,50221,168,2.22 [1.61-3.07],1.2349860097341336e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COLEC12,Collectin-12,49581,165,2.21 [1.38-3.53],0.0009905289172489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CORO6,Coronin-6,41816,123,1.61 [1.13-2.30],0.0087176114524177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPXM2,Inactive carboxypeptidase-like protein X2,43226,128,2.19 [1.36-3.52],0.0012362769541757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIP2,Cysteine-rich protein 2,49224,166,1.69 [1.30-2.21],0.0001116017449097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF1,Macrophage colony-stimulating factor 1,49821,165,2.99 [1.89-4.71],2.5722231901906906e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSRP3,Cysteine and glycine-rich protein 3,41815,123,1.27 [1.10-1.47],0.0008785757886675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST3,Cystatin-C,49726,167,2.20 [1.45-3.33],0.0001964952618159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST7,Cystatin-F,49660,165,1.20 [1.07-1.35],0.0013703186120648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSTB,Cystatin-B,48934,165,1.81 [1.35-2.43],6.521853336181524e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSB,Cathepsin B,49661,168,1.47 [1.16-1.87],0.0016312506244003
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSL,Cathepsin L1,49610,166,2.05 [1.20-3.48],0.008507314410148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSS,Cathepsin S,38986,133,3.01 [1.56-5.82],0.0010634311570636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXADR,Coxsackievirus and adenovirus receptor,49537,166,1.47 [1.15-1.88],0.0020206368617942
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL16,C-X-C motif chemokine 16,50140,168,2.97 [1.72-5.14],9.91455994573761e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL17,C-X-C motif chemokine 17,50157,167,1.57 [1.18-2.09],0.001839196628054
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL9,C-X-C motif chemokine 9,49821,165,1.40 [1.17-1.68],0.0002153830362103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDR1,Epithelial discoidin domain-containing receptor 1,50052,168,2.34 [1.36-4.04],0.0022831472408947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFA1_DEFA1B,Neutrophil defensin 1,48619,163,1.33 [1.07-1.66],0.0099267508080776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB118,Beta-defensin 118,41816,123,1.34 [1.10-1.63],0.0030706348963534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLL1,Delta-like protein 1,49753,165,1.94 [1.27-2.96],0.0021560147825255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPT,Dermatopontin,50221,168,2.81 [1.58-4.97],0.000409098088761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPY30,Protein dpy-30 homolog,49866,168,1.32 [1.08-1.61],0.0065474839749442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSC2,Desmocollin-2,49059,165,1.89 [1.33-2.69],0.0003609845060719
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTNB,Dystrobrevin beta,42937,127,1.81 [1.29-2.54],0.0005463149089627
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTX3,Probable E3 ubiquitin-protein ligase DTX3,49371,166,2.53 [1.61-3.95],5.064236460341719e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EBI3_IL27,Interleukin-27,49949,168,1.76 [1.15-2.70],0.0092120061525698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECSCR,Endothelial cell-specific chemotaxis regulator,41816,123,0.51 [0.30-0.85],0.0095160509576172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDA2R,Tumor necrosis factor receptor superfamily member 27,50024,168,2.39 [1.77-3.23],1.3370411019877394e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDN1,Endothelin-1,42083,123,2.72 [1.59-4.64],0.0002460237490802
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,49726,167,1.96 [1.30-2.94],0.0012485229628817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA1,Ephrin-A1,49537,165,1.98 [1.29-3.04],0.0017940568319596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA4,Ephrin-A4,49142,166,1.83 [1.25-2.68],0.0017534853859776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELN,Elastin,43226,128,2.27 [1.44-3.57],0.0003831553998875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENAH,Protein enabled homolog,48668,162,1.47 [1.13-1.92],0.0037246292088933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA2,Ephrin type-A receptor 2,47811,157,2.12 [1.53-2.94],6.26542512636392e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB4,Ephrin type-B receptor 4,50221,168,2.25 [1.39-3.63],0.0009465862358668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB6,Ephrin type-B receptor 6,49141,166,1.86 [1.25-2.78],0.0024332238551158
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPN1,Epsin-1,42437,128,0.46 [0.27-0.79],0.0050945614636545
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP3,"Fatty acid-binding protein, heart",43226,128,1.53 [1.16-2.02],0.0027198697319576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP4,"Fatty acid-binding protein, adipocyte",50221,168,1.60 [1.25-2.04],0.0001563181523232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3C,Protein FAM3C,49536,166,2.09 [1.37-3.20],0.0006504287055471
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRLB,Fc receptor-like B,48422,162,1.31 [1.10-1.56],0.0021360050186791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FDX1,"Adrenodoxin, mitochondrial",41815,123,1.35 [1.10-1.66],0.003925561627849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF23,Fibroblast growth factor 23,49945,168,1.47 [1.22-1.76],4.402618267323449e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF5,Fibroblast growth factor 5,48668,162,1.66 [1.14-2.43],0.0089684784188408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFR2,Fibroblast growth factor receptor 2,49753,165,2.17 [1.22-3.85],0.0085108704049201
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGL1,Fibrinogen-like protein 1,43258,128,1.50 [1.17-1.92],0.0015613230820364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGR,Tyrosine-protein kinase Fgr,48439,166,1.26 [1.06-1.50],0.0078459729764674
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,49224,166,2.01 [1.28-3.15],0.0025035765365634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT1,Vascular endothelial growth factor receptor 1,49289,166,2.22 [1.47-3.36],0.000157094069635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSTL3,Follistatin-related protein 3,49505,165,2.36 [1.63-3.42],5.026410824341792e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAS6,Growth arrest-specific protein 6,49899,168,2.31 [1.35-3.95],0.0022927919051198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCG,Pro-glucagon,48422,162,1.16 [1.04-1.29],0.0082987522000963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF15,Growth/differentiation factor 15,50221,168,2.18 [1.79-2.66],1.393996242741746e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFAP,Glial fibrillary acidic protein,48344,161,1.91 [1.47-2.49],1.2549378834276944e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA1,GDNF family receptor alpha-1,49949,168,3.33 [2.22-5.01],7.0811353222989165e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGT1,Glutathione hydrolase 1 proenzyme,49537,165,1.45 [1.14-1.85],0.0028316845360331
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPC2,PDZ domain-containing protein GIPC2,43118,128,2.05 [1.25-3.35],0.0042387618879049
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPD1,Glycerol-3-phosphate dehydrogenase,43021,127,1.52 [1.14-2.01],0.0040766381108059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR37,Prosaposin receptor GPR37,48693,163,1.32 [1.07-1.63],0.0096696012799202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPRC5C,G-protein coupled receptor family C group 5 member C,43021,127,1.45 [1.16-1.82],0.0010396166262472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRPEL1,"GrpE protein homolog 1, mitochondrial",49371,166,1.33 [1.08-1.64],0.0072609975188214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR1,Hepatitis A virus cellular receptor 1,49953,168,1.37 [1.13-1.67],0.0015245959010577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR2,Hepatitis A virus cellular receptor 2,49619,166,1.84 [1.30-2.62],0.0006600284921059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDGF,Hepatoma-derived growth factor,49953,167,1.22 [1.06-1.42],0.0063683800791121
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGF,Hepatocyte growth factor,50157,167,2.35 [1.69-3.27],4.691546823677549e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPB6,Heat shock protein beta-6,50024,168,2.06 [1.52-2.79],3.6046100861874655e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNGR1,Interferon gamma receptor 1,49821,165,2.23 [1.28-3.91],0.0048373585698776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP2,Insulin-like growth factor-binding protein 2,50142,168,1.82 [1.46-2.28],1.30700909553332e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP4,Insulin-like growth factor-binding protein 4,48983,164,1.91 [1.49-2.44],2.697301453159196e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP7,Insulin-like growth factor-binding protein 7,50221,168,2.19 [1.68-2.85],6.9829053390233124e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBPL1,Insulin-like growth factor-binding protein-like 1,49610,166,1.99 [1.39-2.84],0.000176378453537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGLC2,Immunoglobulin lambda constant 2,43212,129,1.84 [1.30-2.59],0.0005146292994789
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15,Interleukin-15,49537,166,2.22 [1.56-3.18],1.1207615754968632e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18,Interleukin-18,49417,165,1.48 [1.12-1.95],0.005755094758282
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18BP,Interleukin-18-binding protein,49806,167,1.70 [1.14-2.53],0.0095584608924261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1B,Interleukin-1 beta,48430,160,1.45 [1.19-1.76],0.0002363691263759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1R1,Interleukin-1 receptor type 1,49537,165,2.72 [1.58-4.68],0.0003247472852258
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RN,Interleukin-1 receptor antagonist protein,49492,165,1.47 [1.20-1.82],0.0002637989044068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RA,Interleukin-2 receptor subunit alpha,49260,167,1.52 [1.12-2.06],0.0066581527018057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL4R,Interleukin-4 receptor subunit alpha,49537,166,1.96 [1.43-2.70],3.5314474045349417e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5,Interleukin-5,48668,162,1.13 [1.04-1.22],0.0052679305544701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5RA,Interleukin-5 receptor subunit alpha,49537,166,1.45 [1.15-1.82],0.001451269785495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6,Interleukin-6,49371,166,1.27 [1.11-1.45],0.0006828777099538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMMT,MICOS complex subunit MIC60,43021,127,1.51 [1.11-2.04],0.0077545457419763
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA11,Integrin alpha-11,49537,166,0.53 [0.36-0.79],0.0016831176854458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAV,Integrin alpha-V,50024,168,0.32 [0.14-0.70],0.0047281559447947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGBL1,Integrin beta-like protein 1,43224,130,1.65 [1.14-2.38],0.0079791418949573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,49806,167,1.75 [1.22-2.51],0.0023594119566153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK4,Kallikrein-4,50024,168,1.45 [1.20-1.74],9.838410571041502e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,49581,165,1.55 [1.18-2.04],0.0015951798727579
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP3,Lysosome-associated membrane glycoprotein 3,50075,166,1.54 [1.20-1.99],0.0007850135589113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAYN,Layilin,49141,166,1.62 [1.14-2.31],0.0074823708464775
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LECT2,Leukocyte cell-derived chemotaxin-2,43226,128,1.45 [1.14-1.84],0.0021316486028946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS7_LGALS7B,Galectin-7,49456,166,1.48 [1.15-1.92],0.0027270678376759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS9,Galectin-9,49583,165,1.78 [1.18-2.67],0.0056881345549477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIFR,Leukemia inhibitory factor receptor,49537,166,2.04 [1.19-3.50],0.009140197380649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,48668,162,1.54 [1.14-2.08],0.0044261558128955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMOD1,Leiomodin-1,43149,126,2.10 [1.56-2.83],1.1681291556614828e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,41819,124,1.80 [1.17-2.77],0.0073413887737102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP11,Low-density lipoprotein receptor-related protein 11,49610,166,1.67 [1.17-2.39],0.0047026797483233
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRN1,Leucine-rich repeat neuronal protein 1,48668,162,0.56 [0.40-0.79],0.001105391318678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,42038,121,1.50 [1.11-2.01],0.0082105949849542
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBP2,Latent-transforming growth factor beta-binding protein 2,50221,168,2.43 [1.65-3.59],7.026865176683529e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBR,Tumor necrosis factor receptor superfamily member 3,49336,165,2.02 [1.32-3.09],0.0011053930794107
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MATN2,Matrilin-2,49664,165,2.40 [1.52-3.79],0.0001596449949036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDK,Midkine,49607,165,1.42 [1.15-1.75],0.0012482196497466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MERTK,Tyrosine-protein kinase Mer,50157,167,2.43 [1.46-4.07],0.0007033412505582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP7,Matrilysin,48615,163,1.79 [1.34-2.40],8.748843103505364e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP8,Neutrophil collagenase,49969,168,1.44 [1.22-1.70],1.562710665910725e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP9,Matrix metalloproteinase-9,49545,166,1.57 [1.25-1.96],9.05978400479025e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MNDA,Myeloid cell nuclear differentiation antigen,49534,166,1.19 [1.06-1.33],0.0022333895525519
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPO,Myeloperoxidase,49619,166,1.47 [1.14-1.89],0.0030581910021061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRC1,Macrophage mannose receptor 1,43258,128,2.09 [1.20-3.66],0.0094519442945952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NBL1,Neuroblastoma suppressor of tumorigenicity 1,49753,165,2.28 [1.42-3.67],0.0006576251160166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCF2,Neutrophil cytosol factor 2,49457,166,1.22 [1.07-1.40],0.004079520877958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCS1,Neuronal calcium sensor 1,50024,168,2.59 [1.64-4.09],4.658758498365724e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN2,Nectin-2,49536,166,1.90 [1.25-2.88],0.0026586900464752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEFL,Neurofilament light polypeptide,48287,165,1.85 [1.43-2.40],2.357209990151871e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPC2,NPC intracellular cholesterol transporter 2,42501,128,1.83 [1.26-2.67],0.0016506745543058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPDC1,Neural proliferation differentiation and control protein 1,49610,166,2.12 [1.53-2.94],5.935912424768042e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPPB,Natriuretic peptides B,48693,163,1.24 [1.12-1.37],3.104169465080527e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRP1,Neuropilin-1,49891,167,1.95 [1.22-3.14],0.0057087806800894
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C1A,Cytosolic 5'-nucleotidase 1A,43118,128,2.06 [1.55-2.74],6.661245333316791e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTproBNP,N-terminal prohormone of brain natriuretic peptide,49610,166,1.28 [1.15-1.42],8.121582010432101e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OCLN,Occludin,43149,126,1.63 [1.16-2.29],0.0049364097976725
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGN,Mimecan,49619,166,1.65 [1.22-2.22],0.0011113100012923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OLR1,Oxidized low-density lipoprotein receptor 1,49134,164,1.43 [1.18-1.73],0.0002540140022082
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMG,Oligodendrocyte-myelin glycoprotein,49371,166,0.74 [0.61-0.91],0.0040677199202805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ORM1,Alpha-1-acid glycoprotein 1,43132,129,2.98 [1.36-6.53],0.0064090661045768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSCAR,Osteoclast-associated immunoglobulin-like receptor,49664,165,1.76 [1.18-2.63],0.0052553015191276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSM,Oncostatin-M,49303,166,1.43 [1.18-1.73],0.0002091537085777
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM2,Paralemmin-2,43118,128,2.31 [1.64-3.26],1.7979873397288669e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAM,Peptidyl-glycine alpha-amidating monooxygenase,49979,168,1.97 [1.18-3.29],0.0093753717405812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,41967,124,1.54 [1.11-2.12],0.0086897703620079
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGF,Placenta growth factor,50157,167,2.19 [1.44-3.34],0.0002556925259929
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP1,Peptidoglycan recognition protein 1,49979,168,1.65 [1.26-2.17],0.0003350437461451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,49224,166,2.03 [1.29-3.19],0.0022533035241642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PI3,Elafin,48970,166,1.49 [1.21-1.83],0.0002026420421798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIGR,Polymeric immunoglobulin receptor,48977,164,2.38 [1.69-3.34],5.842701491125715e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,49619,166,1.96 [1.28-3.00],0.0018213774403264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PILRA,Paired immunoglobulin-like type 2 receptor alpha,49619,166,1.71 [1.23-2.37],0.0012493090814729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G15,Phospholipase A2 group XV,49753,165,2.23 [1.38-3.59],0.0010183876446463
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAUR,Urokinase plasminogen activator surface receptor,49265,165,4.02 [2.67-6.06],2.6814439370395044e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLG,Plasminogen,42189,127,2.42 [1.29-4.52],0.0056232704087215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON1,Serum paraoxonase/arylesterase 1,43258,128,0.51 [0.31-0.85],0.0091281079947834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PREB,Prolactin regulatory element-binding protein,48668,162,1.61 [1.14-2.28],0.0074069355574765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRELP,Prolargin,49581,165,2.37 [1.32-4.27],0.0039430267788806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRG2,Bone marrow proteoglycan,43224,130,1.53 [1.13-2.07],0.0061134336043712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROK1,Prokineticin-1,49537,166,1.36 [1.08-1.71],0.0097984432772345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS22,Brain-specific serine protease 4,41967,124,1.57 [1.12-2.18],0.0082769060429077
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PVR,Poliovirus receptor,50052,168,2.00 [1.45-2.76],2.187634549912402e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PYY,Peptide YY,41815,123,1.24 [1.05-1.45],0.0091170092226509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QPCT,Glutaminyl-peptide cyclotransferase,49667,166,2.52 [1.59-3.99],8.005434565972219e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QSOX1,Sulfhydryl oxidase 1,42425,127,1.52 [1.24-1.86],4.824240909906922e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBFOX3,RNA binding protein fox-1 homolog 3,43149,126,1.94 [1.48-2.56],2.19614362511302e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1A,Lithostathine-1-alpha,49316,165,1.41 [1.11-1.80],0.0048046913055479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1B,Lithostathine-1-beta,50221,168,1.34 [1.09-1.66],0.0064172311702044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG3A,Regenerating islet-derived protein 3-alpha,50221,168,1.36 [1.12-1.65],0.001741109188161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG4,Regenerating islet-derived protein 4,49664,165,1.70 [1.34-2.16],1.4438542756976566e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RELT,Tumor necrosis factor receptor superfamily member 19L,49619,166,1.89 [1.24-2.89],0.0030889016147548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REN,Renin,49610,166,1.23 [1.06-1.43],0.0062854290577496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RETN,Resistin,49504,166,1.64 [1.24-2.16],0.0004601549103776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE6,Ribonuclease K6,42961,128,1.65 [1.18-2.31],0.0033227985906536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASET2,Ribonuclease T2,49988,167,2.09 [1.36-3.22],0.0007646535946442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO1,R-spondin-1,49224,166,1.64 [1.14-2.37],0.0082067781434622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO3,R-spondin-3,50024,168,2.63 [1.78-3.89],1.2533462027043378e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A11,Protein S100-A11,49215,165,1.45 [1.17-1.80],0.0007288644790295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A13,Protein S100-A13,41967,124,1.69 [1.15-2.47],0.0074631131824161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAA4,Serum amyloid A-4 protein,43287,129,1.55 [1.17-2.05],0.00233815195421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARB2,Lysosome membrane protein 2,48282,164,2.12 [1.49-3.01],2.8836764606601527e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARF2,Scavenger receptor class F member 2,50052,168,2.38 [1.53-3.69],0.0001115843506647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA11,Serpin A11,50221,168,2.01 [1.43-2.82],5.1872640346527614e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFRP1,Secreted frizzled-related protein 1,49061,166,1.71 [1.33-2.21],3.036812641771642e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPA2,Pulmonary surfactant-associated protein A2,48422,162,1.51 [1.20-1.91],0.0005183258349403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHISA5,Protein shisa-5,43224,130,1.97 [1.34-2.89],0.000567848802474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC1,Sialoadhesin,49821,165,1.52 [1.12-2.08],0.0079936762943065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF8,SLAM family member 8,48422,162,1.50 [1.15-1.95],0.0025678428531101
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC1,SPARC-related modular calcium-binding protein 1,50024,168,1.98 [1.36-2.90],0.0004051928303078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNCG,Gamma-synuclein,49224,166,1.51 [1.22-1.86],0.0001244609567194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK1,Serine protease inhibitor Kazal-type 1,49619,166,1.74 [1.33-2.29],6.085102615209409e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK4,Serine protease inhibitor Kazal-type 4,49537,166,1.32 [1.10-1.60],0.0036529376564427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT1,Kunitz-type protease inhibitor 1,49454,165,2.03 [1.26-3.25],0.0034183945202057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON1,Spondin-1,49664,165,2.16 [1.60-2.91],3.83049386433931e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON2,Spondin-2,49371,165,2.01 [1.38-2.93],0.0002628344432769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPP1,Osteopontin,50142,168,1.49 [1.12-1.98],0.0067084147350182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRPX,Sushi repeat-containing protein SRPX,43226,128,1.96 [1.23-3.13],0.0048432741893741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SULT2A1,Bile salt sulfotransferase,49537,166,1.32 [1.08-1.61],0.0068988011497915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TACSTD2,Tumor-associated calcium signal transducer 2,43944,144,1.76 [1.19-2.60],0.0045272283831804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAFA5,Chemokine-like protein TAFA-5,49371,166,1.72 [1.22-2.42],0.0019840405523429
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCL1A,T-cell leukemia/lymphoma protein 1A,49151,166,0.83 [0.73-0.95],0.0067428054992254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCN2,Transcobalamin-2,50142,168,1.71 [1.17-2.50],0.0059328462175208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF1,Trefoil factor 1,49381,165,1.24 [1.06-1.44],0.0055162581784631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF2,Trefoil factor 2,49744,165,1.51 [1.22-1.87],0.0001553273721137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF3,Trefoil factor 3,49566,167,1.56 [1.25-1.94],7.877570400102439e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFA,Protransforming growth factor alpha,49537,166,1.53 [1.18-2.00],0.0014574980840861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR2,TGF-beta receptor type-2,49753,165,1.72 [1.22-2.43],0.0020893897749087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS2,Thrombospondin-2,49619,166,1.66 [1.21-2.27],0.0014880636917052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS4,Thrombospondin-4,49644,167,1.60 [1.19-2.15],0.0016602041675473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,49806,167,1.49 [1.10-2.01],0.0099425364238528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP1,Metalloproteinase inhibitor 1,49078,166,1.83 [1.19-2.82],0.005952717491371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMSB10,Thymosin beta-10,49619,166,1.27 [1.06-1.52],0.0099627959502924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNC,Tenascin,49806,167,1.48 [1.12-1.94],0.0052303922577214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,49224,166,1.84 [1.37-2.45],4.0111612095975647e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,49224,166,1.35 [1.14-1.60],0.0005293657077591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,50157,167,1.56 [1.14-2.15],0.0061819842996815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,49581,165,2.44 [1.61-3.70],2.7258131451660387e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,49753,165,1.67 [1.17-2.39],0.0049762813555372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,49664,165,1.75 [1.33-2.30],5.870044380854451e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,50024,168,1.73 [1.20-2.50],0.0032342152251103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,49619,166,2.25 [1.54-3.29],2.6984966266471056e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,49619,166,1.53 [1.18-1.98],0.001319077668996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,49224,166,1.41 [1.14-1.73],0.0013105628454939
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF10,Tumor necrosis factor ligand superfamily member 10,50157,167,0.49 [0.29-0.82],0.0073302708104215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,50140,168,1.94 [1.29-2.93],0.0014811761205019
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBQLN3,Ubiquilin-3,41815,123,1.46 [1.18-1.81],0.0004922683161257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCAM1,Vascular cell adhesion protein 1,49726,167,1.86 [1.16-2.96],0.0093736041672987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VNN2,Vascular non-inflammatory molecule 2,49371,166,1.55 [1.13-2.13],0.0061922705663306
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG2,V-set and immunoglobulin domain-containing protein 2,43021,127,1.46 [1.16-1.83],0.0010591800528793
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG4,V-set and immunoglobulin domain-containing protein 4,49550,166,1.69 [1.25-2.29],0.0007115471079754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC2,WAP four-disulfide core domain protein 2,47080,155,2.04 [1.54-2.70],6.366863003876852e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WIF1,Wnt inhibitory factor 1,50024,168,1.89 [1.28-2.79],0.0012671560070591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WNT9A,Protein Wnt-9a,48668,162,1.80 [1.20-2.71],0.0047209563816765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XG,Glycoprotein Xg,49982,168,1.77 [1.22-2.56],0.0026508695619667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XPNPEP2,Xaa-Pro aminopeptidase 2,49753,165,0.84 [0.74-0.95],0.0070829763112687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YAP1,Transcriptional coactivator YAP1,43118,128,3.02 [1.84-4.95],1.2087852931299509e-05
